Translate this page into:
Mixed depression: Toward a conceptual framework
* Corresponding author: Dr. Raman Deep, Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India. drramandeep@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Deep R. Mixed depression: Toward a conceptual framework. Future Health. doi: 10.25259/FH_97_2025
Abstract
Mixed depression remains nosologically fractured and clinically underrecognized, particularly in the context of major depressive disorder (MDD). As a result, a substantial subgroup of patients is overlooked despite high clinical stakes and possibly a severe illness phenotype. Emerging perspectives increasingly recognize a nuanced and complex psychopathology of mixed depression, though significant gaps persist in empirical guidance for treatment. The DSM-5 mixed specifier represents progress but is undermined by paradoxical exclusion of the crucial symptoms commonly observed in mixed depression. ICD-11 is more inclusive of mixed episodes but lacks recognition of subthreshold mixed features or specifiers. This paper discusses the conceptual underpinnings of mixed depression by critically examining how it is currently defined (nosology), how it presents clinically (phenomenology), and what evidence (empirical data) supports or challenges the current framework. To move forward, it is essential ADDIN ZOTERO_TEMP {Citation}to build evidence towards a conceptually coherent, clinically useful foundation to guide clinical care and treatment approach for MDD with mixed symptoms
Keywords
Major depression
Mixed depression
Mixed states
Nosology
Phenomenology
INTRODUCTION
Literature indicates that mixed symptoms are common, clinically consequential, and frequently under-recognized in major depressive disorder (MDD).1-3 In clinical practice, individuals with major depressive episode (MDE) may display a few hypomanic or activation symptoms. When these occur in a depressive episode, the clinical presentation is referred to as mixed depression to differentiate it from ‘pure depression’. In the current classification, ICD-11 lacks recognition of subthreshold mixed features in patients diagnosed with MDD. DSM-5 introduced the specifier “with mixed features” for depressive episode, but its purpose is undermined by the paradoxical exclusion of the commonly observed mixed symptoms such as psychomotor agitation, irritability, and lability. These criteria mark an improvement, but still hinder the optimal recognition, with important clinical implications.4,5
Historical descriptions of agitated depression are broadly similar to the concept of mixed depression. Since the advent of DSM-III in 1980, mood disorders were bifurcated into unipolar and bipolar disorders with an overemphasis on polarity (depression vs mania) that did not acknowledge mixed states in a meaningful way. Further, both DSM-III/DSM-IV and ICD-10 criteria for mixed episodes were impractical to fulfil.1,2 Consequently, mixed presentations became uncommon and under-represented, till their partial revival with DSM-5.
The mixed symptoms when they occur in individuals diagnosed with unipolar depression are either subsumed entirely in the construction of MDD, are dismissed just as a depressive epiphenomenon, or misattributed to concurrent anxiety or personality disorders. Despite diagnostic system revisions, a significant proportion of such patients with mixed symptoms remain undetected. To resolve this crisis, there is a need to bridge the gap between diagnostic constructs and clinical reality, thereby improving patient outcomes.
This paper discusses mixed symptoms in major depression, examining the conceptual and nosological frameworks, along with empirical evidence and critical gaps. At the outset, it should be noted that mixed states exist on a spectrum that includes manic episodes; however, this paper focuses on mixed symptoms in depression, particularly in the context of MDD.
To the extent feasible, the discussion centers on MDEs in MDD, but where separate findings on MDD are not available, it incorporates findings from studies on MDEs with combined samples of unipolar and bipolar depression. All such instances are clearly outlined in the paper.
Furthermore, it is also useful to differentiate the following terms often used in literature, to understand their usage throughout this paper:
-
Mixed features specifier: Current manic, hypomanic, or MDE that also includes ≥3 clinically significant symptoms from the opposite pole, as defined in DSM-5
-
Mixed symptom: any symptom in a mood episode from opposite polarity or is considered to represent a mixed state, irrespective of whether the classificatory system recognizes it or not, e.g., irritable rather than depressed mood, agitation rather than retardation in case of MDE
-
Mixed states (as a phenomenological label): Any clinical state in which manic/hypomanic and depressive symptoms co-occur or have admixtures of varying degree, regardless of how a given classification system labels it. As per the preponderance of symptoms, a depressive mixed state or manic mixed state can be delineated.6
-
Mixed episode (current use in ICD-11; historical use in DSM-IV/ICD-10): A mood episode meeting full syndromic criteria for both manic and depressive syndromes either simultaneously or in very rapid alternation.
THE RISE AND THE FALL LEADING UP TO A RECENT REVIVAL
Sporadic descriptions of mixed states can be found in the writings of Falret, Griesinger, Heinroth, and Flemming. Emil Kraepelin, in the first edition of his textbook, made a mention of “Melancholia Activa” with more specific types emerging later on, such as “involutional melancholia.”
The severe, anxious, and agitated depression of later life (involutional melancholia) was considered by Kraepelin to be a disease distinct from depressions under manic-depressive illness (MDI). A pivotal change in this viewpoint came from the work of Georges Dreyfus, who was a colleague of his. Through meticulous observational studies, Dreyfus argued that involutional melancholia was not a separate entity but rather a manifestation of MDI.7,8 This was based on the hallmark symptoms, profound agitation, anxiety, panic, and restlessness, noting that they were similar to mixed states of MDI that were described in an earlier work of Wilhelm Weygandt.
Working in Kraepelin’s supervision, Weygandt had previously concluded that mixed states are a norm in the context of MDI.7-9 He also developed the now-landmark scheme to explain the mixed states (based on independent dimensions of mood, thought, and volition). As many as six subtypes of mixed states were described, such as agitated depression (negative affect and thought, with increased motility), and depression with flight of ideas (negative affect and volition, with increased thought processes).
Based on the work by Dreyfus (underpinned by Weygandt’s framework), Kraepelin performed a major revision in the 8th Edition (1913) of his textbook, classifying the “involutional melancholia” under the umbrella of MDI.7 Further, Kraepelian perspective treated varying admixtures of manic and depression as a core principle of mood disorders and subsumed all of them under MDI.
In successive decades, the dominant narrative transitioned into the narrower, more precisely defined mood episodes of either polarity under MDI. Agitated depression continued to be recognized till the 1970s, for example, in the Research Diagnostic Criteria (RDC)10, and was later absorbed under major depression in classificatory systems.
With the advent of DSM-III (1980), the diagnostic systems formally bifurcated MDI into unipolar and bipolar disorder, moving to a Leonhardian perspective. This theoretical shift posed an identity crisis for the middle ground of mixed states, though by that time, the mixed states were thought to be too uncommon to merit consideration.
DSM-III-R and DSM-IV attempted to accommodate the phenomenon with a narrowly defined “mixed episode” (requiring simultaneous, full syndromal criteria for mania and major depression every day for a week), a threshold that captured only a fraction of clinically mixed states and reinforced the impression of rarity.
ICD-10 recognized mixed states in two places:
-
F31.6 Bipolar affective disorder, current episode mixed: requires syndromal mania and syndromal depression present most days for at least 2 weeks, either simultaneously or in very rapid alternation- broader in phenomenology than DSM-IV’s “mixed episode,” but confined to categorical diagnosis in bipolar affective disorder.
-
F38.0 Mixed affective episode: a single mixed episode classified under “other mood disorders.” Despite existing on paper, it was sparingly used and offered limited guidance.
CLINICAL SIGNIFICANCE AND IMPACT
Meta-analytic evidence indicates that approximately one-quarter of patients with depression present with admixtures of mixed symptoms.11 Mixed states, in general, are one of the important drivers of adverse course and poor outcomes in mood disorders.
Patients of both MDD and BD with mixed features experience an earlier age of onset, increased risk of psychiatric hospitalization, and higher rates of comorbid anxiety or substance use.12-14 The mixed state during MDE has been linked with suicidal risk in patients with mood disorders.14,15 Longitudinally, the mixed depression manifests more frequent and severe episodes, and spends less time in euthymia. Depression with mixed features has an association with female gender, rapid cycling, and family history of BD, besides an increased risk of conversion to BD diagnosis. Mixed features across mood episodes showed partial stability in a study on patients with BD.16 Further, mixed features could be potentially associated with treatment-emergent affective switches or other iatrogenic risks on conventional antidepressants with higher switch potential.17,18
MIXED DEPRESSION AND DSM-5/ICD-11: MOVING FORWARD, MISSING THE MARK
This contemporary nosology underrepresents the clinical reality of mixed depression. This impedes accurate documentation and confounds research. There is a fundamental divergence in the approach to mixed depressive states between the two classificatory systems, viz, DSM-519 and ICD-11,20 each presenting its own critical challenges.
The DSM-5 made visible changes to integrate dimensionality of mixed states by introducing “mixed features specifier” for MDE (applied to both MDD and BD), which is a pragmatic step to acknowledge dimensionality, but the purpose is ultimately defeated due to fundamentally flawed and paradoxical criteria for “mixed features specifier.” The DSM-5 mandates that for a depressive episode to be specified with mixed features, a patient must experience at least three ‘non-overlapping’ manic symptoms. It deliberately excludes symptoms that were considered core to the concept of mixed depression based on the flawed rationale of their historical inclusion under depression. Consequently, a depressed patient with severe, distressing agitation and intense irritability is excluded from receiving the specifier. Further, the symptoms of elevated or expansive mood and inflated self-esteem or grandiosity that are listed in the mixed features specifier have been found to be highly uncommon in mixed depressive states.1,2,21
Unlike DSM-5, ICD-11 preserves a category of mixed episodes under BD, defined by simultaneous or rapidly alternating depressive and manic symptoms. Interestingly, ICD-11 BD mixed episode criteria says that when depressive symptoms predominate, some of the most common contrapolar features are irritability, distractibility, increased verbal output, and psychomotor agitation, precisely the features that DSM-5 excludes from its mixed features specifier in MDE. ICD-11 lists mixed episodes under the heading of BD. Compared to DSM-5 BD-MDE with mixed features, however, ICD-11 lists more inclusive and non-prescriptive contrapolar symptoms under BD mixed episode, but it imposes a higher threshold by requiring both polarities to alternate or co-exist at the syndromic level.
ICD-11 does not acknowledge mixed specifiers, unlike DSM-5. Therefore, for patients presenting with mixed symptoms in MDE, there is no specifier or diagnostic code in ICD-11 to capture this complexity.
Available literature reports a higher prevalence based on a broader research-based criterion compared to the prevalence defined by the DSM mixed features specifier in MDD. The pooled prevalence was 23.8% in MDD depressive episode (and 35.2% in bipolar depressive episode) for studies using broader criteria of any three contrapolar features.11 On the other hand, a review of studies using DSM-5 defined mixed features reported a pooled prevalence of 11.6% for MDE (and 26.8% for manic episodes).22
Coming to Asian literature, a multicentric study of Indian patients with first-episode depression reported 16% DSM-5-defined mixed features.23 In a study from North India, 21.5% of patients with unipolar depression met DSM-5 mixed-features criteria, similar to the 23.7% reported for bipolar depression in the same study.24 Another large sample from Korea reported a much lower prevalence of DSM-5 mixed features in MDE, particularly in MDD (1.7%), compared with those in bipolar disorder (BD) (15.6%). In contrast, when broader criteria were applied, prevalence rates were substantially higher (MDD: 19%, BD: 61.8%).25
Thus, the clinicians are caught between a DSM-5 system that misrepresents mixed depression by defining it too narrowly and an ICD-11 system that is more inclusive in contrapolar features but overlooks the subsyndromal mixed states.
CONCEPTUAL FOUNDATIONS OF MIXED DEPRESSION
Understanding the ‘Activation’ construct
Available factor-analytic studies on patients in MDE support the presence of an activated/hyperreactive cluster as opposed to retarded/hyporeactive cluster in depressed patients.26,27 Both unipolar and bipolar depression share psychomotor activation as a key latent structure.26
Activation is a construct that refers to the entire range of physiologic manifestations in objectively observed behavior/motor activity or the subjective experiences, including psychic activity. Activation includes agitation as well, but is much broader in scope, also encompassing the subtle phenomena such as reaction times, speech, and thought flow, besides driving the emotions and volitions.28 Though typically associated with mania, activation is a central distinguishing feature of mixed depression from pure depression.
Unlike mania, the activation manifests differently in the context of a depressive episode. A large multinational study of 2,720 subjects (BRIDGE-II-MIX) identified two clusters (mixed and non-mixed) in MDE. Seven clinical features were the best predictors of the mixed depression cluster, viz. irritability, emotional lability, psychomotor agitation, distractibility, mood reactivity, absence of reduced appetite, and absence of psychomotor retardation.27
Expansive symptoms are not the defining features of mixed depression
Research distinguishes between expansive and excitatory (activation) symptoms in mood disorders research. The ‘activation’ (not expansiveness) is the hallmark of mixed depression.26-29 DSM-5 specifier for mixed depression emphasizes expansive elements such as euphoria, decreased need for sleep, inflated self-esteem, and grandiosity, which remain quite uncommon. In contrast, excitatory features, including irritability, psychomotor agitation, inner tension, and racing or crowded thoughts, define the lived experience of mixed depression.
Symptom profile of mixed features in MDE
Most empirical data derived from larger study samples include subjects with either both bipolar and unipolar depression, or with bipolar depression.
A multinational sample of unipolar/bipolar patients in MDE from eight countries (three continents-Africa, Europe, Asia) reported following symptoms in decreasing order of frequency: irritability (32.6%), emotional lability (29.8%), distractibility (24.4%), psychomotor agitation (16.1%), impulsivity (14.5%), aggression (14.2%), racing thoughts (11.8%) and pressured speech (11.4%). Euphoria (4.6%), grandiosity (3.7%), and hypersexuality (2.6%) were less represented).1
The mixed features are more prevalent in bipolar depression, though the broad clinical presentation appears to be similar in both.1,26,30 Two-thirds of the subjects with bipolar depressed episodes in the STEP-BD trial (N=1,380) had mixed symptoms, most often distractibility, flight of ideas or racing thoughts, and psychomotor agitation.31 The main differentiating features of mixed MDE in a large naturalistic longitudinal study of 907 outpatients with BD (Stanley Bipolar Network; >14,000 visits) were irritability, language-thought disorder, increased speech (rate and amount), and heightened motor activity/energy compared to non-mixed MDE.32
Agitation in depression: Depressed or mixed criterion?
Psychomotor agitation has often been operationalized as at least two observable signs: pacing, hand-wringing, inability to sit still, rubbing or pulling hair/skin/clothing, outbursts of complaining or shouting, and overtalkativeness.10,33 Conventionally, agitated depression was conceptualized as a severe form of depression in which psychomotor agitation is the predominant clinical feature, indicative of a mixed state.
One of the striking controversies is regarding the current placement of psychomotor agitation under MDD criteria in ICD-11 (neurovegetative cluster)/DSM-5 (fifth criterion), while excluding it from the DSM-5 mixed specifier based on the unsubstantiated premise that it overlaps with depression. It has been argued, possibly as an afterthought, that psychomotor agitation is diagnostically non-specific. However, the conceptual salience of agitation emerging with temporal onset with or during the MDD episode cannot be overlooked.34
KOUKOPOLOUS’S MIXED DEPRESSION VS AGITATED DEPRESSION
Mixed depression has been conceptually differentiated into forms with and without overt motor agitation. The former corresponds to agitated depression as defined in the Research Diagnostic Criteria (RDC).10
By contrast, Koukopoulos’s mixed depression without psychomotor agitation is characterized primarily by “inner psychic unrest” or “psychic agitation” in the absence of markedly increased motor activity.33,35 Along with a MDE, the presence of at least three of the following eight symptoms is required to define Koukopoulos’s mixed depression: (1) inner tension or agitation; (2) racing or crowded thoughts; (3) irritability or unprovoked rage; (4) absence of psychomotor retardation; (5) talkativeness; (6) dramatic expression of suffering or frequent spells of weeping; (7) mood lability and marked emotional reactivity; and (8) early insomnia. These patients often report unbearable psychic suffering, marked mood lability, and heightened emotional reactivity.
The concept of Koukopolous’s mixed depression is in alignment with the historical concept, though research to validate the scale is limited. At least one study demonstrated internal consistency and inter-rater reliability to be adequate for the Koukopolous Mixed Depression Rating Scale (KMDRS).33
OVERLAP OF MIXITY AND ANXIETY SPECIFIERS IN DSM-5 MIXED DEPRESSION
There is some research to indicate that patients with excitatory symptoms in MDD are often categorized under anxious distress rather than as mixed depression in DSM-5, and that their criteria have some overlapping aspects.36 Anxious distress specifier requires presence of at least two of the following symptoms for most days: (a) feeling keyed up or tense; (b) feeling unusually restless; (c) difficulty concentrating because of worry; (d) fear that something awful may happen; and (e) feeling that the individual might lose control of himself or herself.
A network analyses for symptom relationships support this diagnostic entanglement, showing that symptoms like irritability, agitation, and anxiety cluster together, bridging depressive and hypomanic domains.37 Together, these findings highlight that some criteria in anxiety specifiers are not clearly separable from mixed depression, leading to under-recognition of mixed states.
DIMENSIONAL OR NON-CATEGORICAL APPROACHES TO MIXED STATES
Several-dimensional frameworks attempt to conceptualize mixed states.26 To start, it is useful to add that none of these approaches is without limitations, and these do not provide a complete explanatory framework. While some are supported by some data, the evidence remains limited for others, and key issues of validity and clinical utility persist
-
Additive (combinatorial) approach: These approaches view mixed states as the co-occurrence of depressive and manic symptoms in varying combinations, reflecting overlap between opposite poles. Kraepelian-Wegandt framework9,38 is an example of this approach. The DSM-5 criteria also involve an additive approach.19
-
Emergent (non-combinatorial) approaches: In contrast to the above, the Vienna school conceptualized mixed states as emergent biological conditions of contradictory arousal and affect. This approach views mixed states as a qualitatively new state that is sustained by dysregulated systems of arousal and affective drive.26,39
-
Affective Temperament Model: This emphasizes that mixed episodes can emerge when acute mood states interact with temperamental traits, e.g., cyclothymia or hyperthymia. For instance, depression in a hyperthymic temperament may present as mixed depression.40,41
-
Staging and spectrum perspectives: Duffy’s clinical staging model treats mood disorders as evolving across phases, with mixed presentations marking unstable transition points rather than discrete categories.42 Benazzi’s spectrum work situates mixed depression as the linking phenotype along a unipolar–bipolar continuum. Together, these approaches imply gradations that are missed by rigid categorical thresholds.43
-
RDoC framework: The Research Domain Criteria (RDoC)44 position mixed states across multiple functional domains: negative valence (distress, anhedonia), positive valence (reward dysregulation), arousal/regulatory systems (hyperactivation), and cognitive control (racing/crowded thoughts). This reflects multi-system dysfunction.
-
HiTOP model: The Hierarchical Taxonomy of Psychopathology (HiTOP)45 situates mixed states within the internalizing spectrum, but overlapping with bipolarity and disinhibited externalizing. Symptoms like irritability, agitation, and emotional lability are transdiagnostic disturbances in mood regulation and arousal
-
Network theory: From a dynamic perspective driven by network theory,46 mixed states are viewed as unstable but self-reinforcing symptom networks, where activation in one cluster (e.g., irritability, agitation) amplifies or sustains depressive affect, creating a perpetuating cycle. A recent study on patients with acute depression across MDD and BD found that mixed symptoms were the most central and highly interconnected nodes in the network, particularly agitation, followed by irritability. Further, mixed symptoms such as appetite gain and hypersomnia were associated with BD rather than MDD, suggesting a possible stratification within mixed states.47
Integrating phenomenology with biological signatures of mixed depression
Limited but converging evidence from neurobiological studies (neurochemical, HPA, circadian, neuroimaging) indicates hyperarousal and hyperactivation as central signatures of depressive mixed states.48
Liu et al49 demonstrated heightened connectivity within the default mode network (DMN) in patients with mixed features in MDE, which intensify the self-referential and emotional dysregulation processes. Limited studies assessing neurobiological alterations in mixed depression appear to distinguish it from non-mixed MDD and controls.48 However, further research specific to mixed states is required. Approaches such as digital phenotyping of mood states can provide additional data inputs. A preliminary study using a Machine Learning approach on the speech features showed the ability to reliably distinguish mixed depression from pure depression.50
BRIDGING CLINICAL GAPS IN MIXED DEPRESSION
Measuring mixed depression: Clinical utility of existing scales
Overall, mixed depression lacks many well‐validated, specific instruments; only a few tools are purposefully developed.33,51 Clinicians often combine existing scales in clinical settings, for example, HAM-D or MADRS (depression) with YMRS (mania), though this approach lacks formal validation. Similarly, the Quick Inventory of Depressive Symptomatology (QIDS-C) has been paired with Young’s mania rating scale (YMRS) cut-offs to identify mixed depression in research studies (e.g., QIDS-C ≥15 with YMRS >2 and <12).
The Clinically Useful Depression Outcome Scale with mixed-features subscale (CUDOS-M)51 corresponds directly to DSM-5 mixed‐features in depression and has good psychometric properties. It is a self-report scale with some barriers in application without translation and cultural adaptation.
The Koukopoulos Mixed Depression Rating Scale (KMDRS) was developed to assess mixed depression as defined by Koukopolous.33 This scale is not aligned with DSM-5 criteria; it captures the symptoms and their severity of broadly-defined mixed depression. Despite its divergence from classificatory systems, it can offer an additional or supplemental tool for eliciting phenomenology and/or conducting research.
Another approach is Benazzi’s mixed depression (BMD) criteria,52 which emphasize the coexistence of depressive episodes with at least three concurrent hypomanic symptoms. While not formally adopted in the current nosology, these criteria offer a broader and more clinically representative framework
Managing mixed depression: Need for empirical treatment data
There is a paucity of randomized controlled trials directly addressing treatment strategies for the acute treatment of MDD with mixed features. Extrapolations from studies on BD manic or mixed presentations have their limitations. Older treatment trials often combined patients with mixed and manic episodes, blurring conclusions specific to mixed depression.
Below is the synthesis of available limited evidence and various guidelines:
Recently, a 6-week double blind RCT evaluated lumateperone among a combined MDD/BD patient population, finding its efficacy for MDE with mixed features.53 Besides, it was also effective for the individual MDD with mixed features subgroup in this study, for which significant improvements started at the end of week 1 for YMRS and at the end of week 2 for MADRS total score, maintained till the end of week 6, indicating a sustained improvement in MDD with mixed features (similar to BD group with mixed features).
The 2020 Royal Australian & New Zealand College of Psychiatrists Guidelines for Mood Disorders6 acknowledge the lack of sufficient data for mixed features in MDD, instead giving a broad guidance on mixed states (depending on severity or preponderance of polarities. While managing any mixed state, first-line preference should be given to agents that have efficacy for acute treatment across both poles and with mood-stabilizing properties, namely lithium, valproate, and quetiapine, to minimize contrapolar induction and avoid exacerbating mixed features. If monotherapy is insufficient, combinations of these agents, for example, lithium plus quetiapine, may be used. Cariprazine or ziprasidone may also be considered because each has some efficacy across poles. Further, lurasidone (or olanzapine as an alternative) may be considered when treating mixed depression specifically. Finally, electroconvulsive therapy (ECT) remains an important option.
The 2023 update for the CANMAT-ISBD guideline for management of MDD54 acknowledges the absence of robust evidence to manage MDD with mixed features specifier. It advises that a specialist (psychiatrist) should treat such conditions. Given the paucity of treatment data for MDD with mixed features, it does not make a differentiation in the first-line treatment of MDD with mixed features from non-mixed MDD, except for a note of caution advising to monitor closely for activating side effects of antidepressants. Lurasidone is recommended as a second-line agent for patients with MDD and mixed features. Just to compare the above MDD guidelines to the 2021 CANMAT-ISBD guidelines on management of BD with mixed presentations (MDD not covered here),55 there is no agent that meets the threshold for first-line treatment for DSM-5 BD depressive episodes with mixed features. Both cariprazine and lurasidone were recommended as second-line options based on limited evidence, with olanzapine or olanzapine-fluoxetine as third-line. Available evidence in these guidelines was mostly based on post-hoc analysis of RCT data using proxy DSM-5 criteria.
Finally, foundations of care should also include non-pharmacological treatment for MDD, comprising psychotherapies, psychoeducation, lifestyle stabilization, and psychotherapies, as applicable. There is limited guidance on long-term treatment or maintenance for mixed depression in either MDD or BD, in part because of the recent DSM-5 changes.
Moving forward, systematic trials specifically designed to evaluate interventions in depressive mixed states are essential to ensure both clinical safety and therapeutic efficacy. Further, the mixed depression marks an important link between the unipolar-bipolar continuum, which needs to be revisited and researched in light of contemporary understanding of mixed symptoms.43
CONCLUSION
Mixed states, particularly those in MDD, remain clinically unrecognized and nosologically fractured. Contemporary perspectives increasingly recognize the nuanced and complex nature of mixed depression. Both ICD-11/DSM-5 represent progress, but critical challenges remain in both classificatory systems. Further, significant empirical gaps persist, particularly in the context of MDD, with limited treatment trials to guide its management. There is a need to move toward a more conceptually coherent and clinically useful framework for mixed depression, with implications for diagnosis and treatment.
Author contribution
RD: Conceptualized the topic, analyzed and synthesized the evidence, drafted and revised the manuscript, and approved the final version.
Ethical approval
Institutional Review Board approval is not required.
Declaration of patient consent
Patient’s consent not required as there are no patients in this study.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of Artificial Intelligence (AI)-Assisted Technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
References
- Mixed features in patients with a major depressive episode: The BRIDGE-II-MIX study. J Clin Psychiatry. 2015;76:e351-8.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed features in depression. Psychiatric Clinics of North America. 2020;43:59-68.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed states in DSM-5: Implications for clinical care, education, and research. J Affect Disord. 2013;148:28-36.
- [CrossRef] [PubMed] [Google Scholar]
- Major depressive disorder with subthreshold hypomanic (mixed) features: A real-world assessment of treatment patterns and economic burden. J Affect Disord. 2017;210:332-7.
- [CrossRef] [PubMed] [Google Scholar]
- Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry. 2011;168:40-8.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- The 2020 Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021;55:7-117.
- [CrossRef] [PubMed] [Google Scholar]
- Origin and development of concepts of bipolar mixed states. J Affect Disord. 2001;67:229-40.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed features: Evolution of the concept, past and current definitions, and future prospects. CNS Spectr. 2017;22:161-9.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed States: Historical impact and evolution of the concept. Psychiatr Clin North Am. 2020;43:1-13.
- [CrossRef] [PubMed] [Google Scholar]
- Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry. 1978;35:773-82.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed symptoms in major depressive and bipolar disorders: A systematic review. J Affect Disord. 2018;225:756-60.
- [CrossRef] [PubMed] [Google Scholar]
- The prevalence and illness characteristics of DSM-5-defined “mixed feature specifier” in adults with major depressive disorder and bipolar disorder: Results from the International mood disorders collaborative project. Journal of Affective Disorders. 2015;172:259-64.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed depression: A mini-review to guide clinical practice and future research developments. Brain Sci. 2022;12:92.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Characteristics of depressive and bipolar disorder patients with mixed features. Acta Psychiatr Scand. 2018;138:243-52.
- [CrossRef] [PubMed] [Google Scholar]
- Depressive mixed state and anxious distress as risk factors for suicidal behavior during major depressive episodes. Sci Rep. 2025;15:11918.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disord. 2009;11:867-75.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Activated depression: Mixed Bipolar Disorder or Agitated Unipolar Depression? Curr Psychiatry Rep. 2013;15
- [CrossRef] [Google Scholar]
- What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier? CNS Spectr. 2017;22:120-5.
- [CrossRef] [PubMed] [Google Scholar]
- Diagnostic and statistical manual of mental disorders (5th ed). Arlington (VA): American Psychiatric Publishing; 2013.
- International classification of diseases for mortality and morbidity statistics (11th Revision). Geneva: World Health Organization; 2019. Available from: https://icd.who.int
- Guidelines for the recognition and management of mixed depression. CNS Spectr. 2017;22:203-19.
- [CrossRef] [PubMed] [Google Scholar]
- Prevalence of DSM-5 mixed features: A meta-analysis and systematic review. J Affect Disord. 2021;282:203-10.
- [CrossRef] [PubMed] [Google Scholar]
- Prevalence of mixed features in patients with first-episode depression: An exploratory multicentric study. Indian J Psychiatry. 2023;65:671-9.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- A comparative study of prevalence of mixed features in patients with unipolar and bipolar depression. Asian J Psychiatr. 2023;81:103439.
- [CrossRef] [PubMed] [Google Scholar]
- The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: A multicenter study based on the DSM-5. Int J Methods Psychiatr Res. 2019;28:e1773.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Psychopathology of mixed states. Psychiatr Clin North Am. 2020;43:27-46.
- [CrossRef] [PubMed] [Google Scholar]
- The role of overlapping excitatory symptoms in major depression: Are they relevant for the diagnosis of mixed state? J Psychiatr Res. 2019;115:151-7.
- [CrossRef] [PubMed] [Google Scholar]
- Activation in bipolar disorders: A systematic review. JAMA Psychiatry. 2017;74:189-96.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed features of depression: Why DSM-5 is wrong (and so was DSM-IV) Br J Psychiatry. 2013;203:3-5.
- [CrossRef] [PubMed] [Google Scholar]
- Bipolar mixed states: An international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry. 2013;170:31-42.
- [CrossRef] [PubMed] [Google Scholar]
- Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: Findings from the STEP-BD. Am J Psychiatry. 2009;166:173-81.
- [CrossRef] [PubMed] [Google Scholar]
- Mixed depression in bipolar disorder: Prevalence rate and clinical correlates during naturalistic follow-up in the stanley bipolar network. Am J Psychiatry. 2016;173:1015-23.
- [CrossRef] [PubMed] [Google Scholar]
- The Koukopoulos Mixed Depression Rating Scale (KMDRS): An International Mood Network (IMN) validation study of a new mixed mood rating scale. J Affect Disord. 2018;232:9-16.
- [CrossRef] [PubMed] [Google Scholar]
- Does psychomotor agitation in major depressive episodes indicate bipolarity? Evidence from the Zurich study. Eur Arch Psychiatry Clin Neurosci. 2009;259:55-63.
- [CrossRef] [PubMed] [Google Scholar]
- DSM-5: A farewell to mixed depression? Int J Bipolar Disord. 2014;2:10.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disorders. J Affect Disord. 2019;245:819-26.
- [CrossRef] [PubMed] [Google Scholar]
- The relationship between depression with anxious distress DSM-5 specifier and mixed depression: A network analysis. CNS Spectr. 2021;26:251-7.
- [CrossRef] [PubMed] [Google Scholar]
- Modelling mood disorders: An ACE solution? Bipolar Disord. 2018;20 Suppl 2:4-16.
- [CrossRef] [PubMed] [Google Scholar]
- Diagnostic criteria for schizophrenic and affective psychoses. Washington: World Psychiatric Press; 1983.
- The distinctive mixed states of bipolar i, II, and III. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:632A-3.
- [CrossRef] [PubMed] [Google Scholar]
- Impact of temperamental mood lability on depressive mixed state. Psychopathology. 2006;39:19-24.
- [CrossRef] [PubMed] [Google Scholar]
- Toward a comprehensive clinical staging model for bipolar disorder: Integrating the evidence. Can J Psychiatry. 2014;59:659-66.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- The continuum/spectrum concept of mood disorders: Is mixed depression the basic link? Eur Arch Psychiatry Clin Neurosci. 2006;256:512-5.
- [CrossRef] [PubMed] [Google Scholar]
- Revolutionizing the study of mental disorders. The Research Domain Criteria Initiative (RDoC); 2024.
- The hierarchical taxonomy of psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J Abnorm Psychol. 2017;126:454-77.
- [CrossRef] [PubMed] [Google Scholar]
- A network theory of mental disorders. World Psychiatry. 2017;16:5-13.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Symptom networks in acute depression across bipolar and unipolar disorders: Centrality of mixed symptoms. Eur Psychiatry. 2020;63:e63.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- The neurobiology of mixed states. Psychiatr Clin North Am. 2020;43:139-51.
- [CrossRef] [PubMed] [Google Scholar]
- Functional connectivity of the default mode network subsystems in patients with major depressive episodes with mixed features. Gen Psychiatr. 2022;35:e100929.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Vocal features obtained through automated methods in verbal fluency tasks can aid the identification of mixed episodes in bipolar disorder. Transl Psychiatry. 2021;11:415.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder. J Affect Disord. 2014;168:357-62.
- [CrossRef] [PubMed] [Google Scholar]
- Bipolar II depressive mixed state: Finding a useful definition. Compr Psychiatry. 2003;44:21-7.
- [CrossRef] [PubMed] [Google Scholar]
- Lumateperone for the treatment of major depressive disorder with mixed features or bipolar depression with mixed features: A randomized placebo-controlled trial. J Clin Psychopharmacol. 2025;45:67-75.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Canadian network for mood and anxiety treatments (CANMAT) 2023 Update on clinical guidelines for management of major depressive disorder in adults. Can J Psychiatry. 2024;69:641-687.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disord. 2021;23:767-88.
- [CrossRef] [PubMed] [Google Scholar]
